Physiopharmacology
The laboratory of Physiopharmacology is affiliated with the Faculty of Medicine and Health Sciences and the Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, and represents one joint research group that bundles its expertise to focus on cardiovascular disease.
Key publications​
- Fluoroquinolones and the risk of aortic aneurysm or aortic dissection: evidence from a nationwide nested case-control study paralleled with matched experimental models. Wesley et al. Eur Heart J Open. 2025
- Programmed death of macrophages in atherosclerosis: mechanisms and therapeutic targets. De Meyer et al. Nat Rev Cardiol. 2024.
- Small-molecule-induced ERBB4 activation to treat heart failure. Cools et al. Nat Comm. 2025;16:576.
Research consortia
The research group Physiopharmacology is part of the Infla-Med Research Consortium of Excellence and coordinates the INSPIRE H2020 PhD project.
